Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
Status:
Completed
Trial end date:
2016-02-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of a novel nicotine product
for continuous abstinence from smoking. Efficacy of product will be evaluated by assessments
of self-reported abstinence, verified by exhaled carbon monoxide (CO) levels.
Phase:
Phase 3
Details
Lead Sponsor:
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.